🚀 VC round data is live in beta, check it out!
Largest Public Companies in the UK
Benchmark revenue and EBITDA valuation multiples for public comps like
HSBC, AstraZeneca, Shell, Rio Tinto UK and Unilever.
 | $18 | +52% | $304B | $262B | 3.7x | — | ||
| $94 | +25% | $291B | $316B | 5.3x | 15.2x | ||
| $42 | +11% | $235B | $280B | 1.0x | 5.0x | ||
| $98 | +66% | $160B | $174B | 3.0x | 7.0x | ||
| $71 | +3% | $155B | $182B | 3.0x | 13.4x | ||
| $18 | +81% | $149B | $147B | 5.3x | 25.6x | ||
| $61 | +45% | $133B | $175B | 4.9x | 10.4x | ||
| $124 | +17% | $132B | $129B | 26.6x | 56.3x | ||
| $29 | +49% | $116B | $135B | 3.0x | 8.9x | ||
| $7 | +14% | $102B | $138B | 0.7x | 3.8x | ||
| $19 | +39% | $93B | $148B | 5.7x | 13.7x | ||
| $30 | +44% | $87B | $94B | 2.4x | 16.2x | ||
| $6 | +52% | $80B | $173B | 4.3x | — | ||
| $1 | +34% | $76B | $107B | 4.1x | — | ||
| $35 | -32% | $63B | $72B | 5.5x | 13.7x | ||
| $8 | +27% | $61B | $50B | 2.2x | — | ||
| $117 | -23% | $59B | $67B | 5.5x | 10.9x | ||
| $85 | +17% | $55B | $66B | 3.5x | 11.8x | ||
| $55 | +149% | $55B | $57B | 6.4x | 10.5x | ||
| $23 | +52% | $52B | $73B | 3.5x | — | ||
| $30 | -12% | $51B | $57B | 1.2x | 11.8x | ||
| $45 | +39% | $48B | $57B | 3.0x | 8.5x | ||
| $21 | -20% | $48B | $68B | 3.5x | 10.5x | ||
| $5 | +2% | $47B | $57B | 3.8x | 14.8x | ||
| $104 | +19% | $46B | $58B | 2.3x | 13.1x | ||
| PE & VC+1 | $43 | -11% | $44B | $45B | 5.2x | 5.4x | |
| $36 | +69% | $43B | $57B | 4.2x | 12.9x | ||
| $6 | +44% | $40B | $54B | 0.6x | 8.2x | ||
| $29 | +68% | $38B | $64B | 2.4x | 8.8x | ||
| $15 | +35% | $37B | $37B | 5.6x | 10.7x | ||
| $1 | +55% | $35B | $79B | 1.7x | 5.9x | ||
| $42 | +10% | $33B | $44B | 3.4x | 7.8x | ||
| $36 | -24% | $33B | $38B | 4.6x | 12.8x | ||
| -- | $71 | +30% | $30B | $40B | 3.6x | 8.0x | |
| $9 | +23% | $28B | $9B | 0.2x | 3.1x | ||
| $3 | +28% | $27B | $56B | 2.1x | 5.1x | ||
| $5 | +54% | $24B | $31B | 0.8x | 3.4x | ||
| $48 | -1% | $22B | $37B | 1.8x | 11.4x | ||
| $8 | +41% | $21B | $23B | 35.8x | 118.2x | ||
| $55 | +60% | $21B | $22B | 6.3x | 25.4x | ||
| $176 | +19% | $20B | $22B | 2.5x | 11.1x | ||
| $28 | +178% | $20B | $16B | 1471.2x | (13.6x) | ||
| $4 | +10% | $20B | $10B | 0.5x | 4.2x | ||
| $132 | +19% | $20B | $23B | 4.4x | 17.3x | ||
| $120 | +129% | $19B | $21B | 5.2x | 23.1x | ||
| $25 | -1% | $18B | $21B | 0.8x | 6.1x | ||
| $5 | +118% | $17B | $23B | 3.7x | 7.5x | ||
| $16 | +25% | $17B | $19B | — | — | ||
| $69 | +185% | $17B | $17B | 3.8x | 6.7x | ||
| $6 | +30% | $15B | $19B | 2.8x | 13.0x | ||
| $11 | +20% | $15B | $21B | 22.1x | 25.7x | ||
| $17 | +21% | $15B | $18B | 2.8x | 10.9x | ||
| $11 | +4% | $14B | $18B | 3.2x | 10.5x | ||
| $44 | +29% | $13B | $25B | 6.8x | 14.2x | ||
| $19 | +38% | $13B | $25B | 7.4x | 12.3x | ||
| $47 | +51% | $12B | $14B | 3.9x | 16.6x | ||
| $8 | +69% | $12B | $5B | 1.5x | 4.4x | ||
| $40 | +4% | $12B | $13B | 1.7x | 10.3x | ||
| $3 | +29% | $12B | $10B | 0.3x | 5.4x | ||
| $12 | -8% | $12B | ($8B) | (3.7x) | (11.7x) | ||
| $35 | +36% | $11B | $11B | 2.7x | 14.5x | ||
| $11 | -30% | $10B | $12B | 3.5x | 13.1x | ||
| $5 | +8% | $10B | $14B | 0.6x | 7.3x | ||
| $5 | +46% | $10B | $17B | 0.4x | 5.7x | ||
| $17 | +39% | $10B | $10B | 1.6x | 8.3x | ||
| $74 | +46% | $10B | $10B | 5.0x | 20.2x | ||
| $4 | +58% | $10B | $12B | 8.3x | — | ||
| $56 | +13% | $10B | $13B | — | — | ||
| $63 | -5% | $10B | $11B | 2.4x | 10.8x | ||
| $30 | -24% | $10B | $13B | 0.8x | 8.2x | ||
| $7 | +18% | $9B | $12B | 2.4x | 10.7x | ||
| $38 | +50% | $9B | $10B | 3.3x | 14.0x | ||
| $18 | +90% | $9B | $10B | 1.4x | 13.5x | ||
| $18 | +35% | $9B | $1B | 1.3x | 2.6x | ||
| $5 | +43% | $8B | $10B | 0.6x | 5.8x | ||
| $17 | +18% | $8B | $9B | — | — | ||
| $13 | -22% | $8B | $10B | 2.0x | 8.9x | ||
| $235 | +26% | $8B | $8B | 8.9x | 19.8x | ||
| $103 | +26% | $8B | $9B | 3.8x | 15.9x | ||
| $7 | +77% | $8B | $8B | — | — | ||
| $10 | +218% | $7B | $6B | 5.0x | 8.9x | ||
| $5 | -16% | $7B | $6B | 0.8x | 8.1x | ||
| $17 | +10% | $6B | $7B | — | — | ||
| $3 | -4% | $6B | $8B | 3.2x | 12.0x | ||
| $22 | -16% | $6B | $6B | 4.6x | 7.5x | ||
| $12 | +22% | $6B | $7B | 2.0x | 9.5x | ||
| $19 | +23% | $6B | $6B | 1.3x | 9.3x | ||
| $144 | +98% | $6B | $11B | 6.6x | — | ||
| $18 | +40% | $6B | $5B | 3.7x | 8.3x | ||
| $10 | +59% | $6B | $5B | 7.2x | 11.3x | ||
| $69 | +0% | $6B | $7B | 0.3x | 6.2x | ||
| $4 | +29% | $6B | $10B | 1.0x | 1.5x | ||
| $34 | +4% | $6B | $12B | 3.1x | 8.6x | ||
| $40 | +2% | $6B | $6B | 2.7x | 11.3x | ||
| $57 | +19% | $5B | $5B | 1.6x | 7.9x | ||
| $23 | +161% | $5B | $11B | 2.6x | 5.1x | ||
| $3 | +44% | $5B | $6B | 3.5x | 13.9x | ||
| $15 | +44% | $5B | $7B | 2.1x | 9.6x | ||
| $6 | -36% | $5B | $5B | 6.2x | 9.3x | ||
| $1 | +2% | $5B | $5B | 0.9x | 8.4x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of last 12 months. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.